Neurogene Inc. (NGNE)

NASDAQ: NGNE · Real-Time Price · USD

14.52

-0.81 (-5.28%)

At close: Mar 28, 2025, 4:00 PM

14.59

+0.07 (0.45%)

After-hours: Mar 28, 2025, 6:55 PM EDT

Neurogene Employees

Neurogene had 91 employees as of December 31, 2023. The number of employees increased by 9 or 10.98% compared to the previous year.

Employees

91

Change (1Y)

9

Growth (1Y)

10.98%

Revenue / Employee

$10,165

Profits / Employee

-$825,758

Market Cap

216.78M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	91	9	10.98%
Dec 31, 2022	82	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

NGNE News

6 days ago - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates - Business Wire
4 weeks ago - Neurogene to Participate in Upcoming Conferences - Business Wire
4 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out - Accesswire
4 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Shareholders to Learn More About the Investigation - Accesswire
4 months ago - Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
4 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Shareholders to Inquire about Securities Investigation - Accesswire
4 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Investors to Connect - Accesswire
4 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Stockholders to Inquire about Securities Investigation - Accesswire